Clinical Trials Sponsored by Akashi Therapeutics

Total 6405 results

Akashi Therapeutics

Terminated

HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02

Duchenne Muscular Dystrophy

United States
AKARI Therapeutics

Recruiting

Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy

Thrombotic Microangiopathies

United States, United Kingdom, Poland
AKARI Therapeutics

Withdrawn

Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) (ARREST-BP)

Bullous Pemphigoid

United States, Germany, Netherlands, Poland
AKARI Therapeutics

Completed

rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects

Bullous Pemphigoid (BP)

Germany, Netherlands
AKARI Therapeutics

Completed

Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576 (CAPSTONE)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Kazakhstan, Lithuania, Sri Lanka
AKARI Therapeutics

Terminated

rVA576 (Coversin) Long Term Safety and Efficacy Surveillance Study (CONSERVE)

Paroxysmal Nocturnal Hemoglobinuria

Poland
Asahi Kasei Medical Co., Ltd.
Asahi Kasei Medical Europe GmbH

Terminated

A Study of Leukocytapheresis (LCAP) in Patients With Ulcerative Colitis (UC)

Ulcerative Colitis

United Kingdom, Japan, Germany, Sweden, Israel, Czech Republic
Asahi Kasei Pharma Corporation

Completed

A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis

Lupus Nephritis

China
Asahi Kasei Pharma Corporation

Completed

A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome

Nephrotic Syndrome

China
Asahi Kasei Pharma Corporation

Completed

Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment

Disseminated Intravascular Coagulation

Japan
Asahi Kasei Pharma Corporation

Completed

Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke

Severe Upper Limb Hemiplegia

Japan
Asahi Kasei Pharma Corporation

Completed

Study of AK156 in Primary Osteoporosis Patients

Osteoporosis

Japan
Asahi Kasei Pharma Corporation

Recruiting

Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

China
Asahi Kasei Pharma Corporation

Completed

Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer

Postoperative Stage II/III Colon Cancer

Japan
Asahi Kasei Pharma Corporation

Completed

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

Diabetes

United States
Asahi Kasei Pharma Corporation

Completed

Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Japan
Asahi Kasei Pharma Corporation

Completed

Clinical Study of AK159 in Healthy Postmenopausal Women

Osteoporosis

Japan
AKARI Therapeutics

Enrolling by invitation

Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms (CONSENTII)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United States
AKARI Therapeutics

Terminated

Topical rVA576 for Treatment of Atopic Keratoconjunctivitis

Atopic Keratoconjunctivitis (AKC)

United Kingdom
Asahi Kasei Pharma Corporation

Completed

Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis

Deep Mycosis

Japan
Asahi Kasei Pharma Corporation

Completed

Collagenase Option for Reduction of Dupuytren's Contracture in Japan (CORD-J)

Dupuytren's Contracture

Japan
Asahi Kasei Pharma Corporation

Completed

A Phase I Study of AK159 in Healthy Postmenopausal Women

Osteoporosis

Japan
Asahi Kasei Pharma Corporation

Completed

A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Poland, Ukraine, Germany, Hungary, United Kingdom, Slovakia, Czech Republic
Asahi Kasei Pharma Corporation

Completed

A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Germany, Romania, Hungary, Lithuania, Czech Republic, United Kingdom
Asahi Kasei Medical Co., Ltd.

Terminated

Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM)

Cardiomyopathy, Dilated

United States
Celsus Therapeutics PLC

Terminated

Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% (C012013)

Atopic Dermatitis

Israel
Asahi Kasei Pharma America Corporation

Completed

Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy

Severe Sepsis | Coagulopathy

Korea, Republic of, United States, Taiwan, Netherlands, United Kingdom, Australia, Canada, Belgium, Israel, Spain, New Zealand, France, Brazil, India, Argentina, Bulgaria, Croatia, Czechia, Finland, Germany, Hungary, Peru, Russian Federation and more
Asahi Kasei Medical Co., Ltd.

Completed

Clinical Study of Asahi ViE Dialyzer in Canada (AVID)

Kidney Failure, Chronic
Asahi Kasei Pharma America Corporation

Withdrawn

The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy (Scarlet2)

Sepsis and Coagulopathy
Asahi Kasei Pharma Corporation
Emergent Clinical Consulting, LLC

Terminated

First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) (ENHANCE)

Spinal Stenosis | Degenerative Spondylolisthesis

Canada
AKARI Therapeutics
Radboud University Medical Center

Completed

Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH)

Paroxysmal Nocturnal Haemoglobinuria (PNH)

Netherlands
ZOLL Circulation, Inc., USA
Asahi Kasei Medical Co., Ltd.

Completed

Therapeutic Hypothermia With IntraVascular Temperature Management (IVTM) in Post-Cardiogenic Cardiac Arrest and Post-Return of Spontaneous Circulation Patients in Japan

Cardiac Arrest

Japan
Portsmouth Hospitals NHS Trust
Akari Therapuetics

Completed

The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19

Coronavirus

United Kingdom
Afasci Inc

Recruiting

Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers

Pain, Neuropathic | Pain, Inflammatory

United States
Acasti Pharma Inc.

Active, not recruiting

Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects

Ataxia Telangiectasia

Canada
Marashi Eye Clinic

Unknown

Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Retinal Disorders

Diabetic Macular Edema, Cystoid Macular Edema, Chorodial Neovascularzation, Posterior Uveitis

Syrian Arab Republic
Marashi Eye Clinic

Completed

PRP vs Bevacizumab for PDR Treatment

Proliferative Diabetic Retinopathy

Syrian Arab Republic
Marashi Eye Clinic

Completed

3 Month Outcome of Ziv-aflibercept for DME

Diabetic Macular Edema
Kashiv BioSciences, LLC

Recruiting

PK, PD, Safety & Immunogenicity of ADL-018 Lyo in Healthy Adult Subjects

Healthy

India
Kashiv BioSciences, LLC

Completed

Open Label, Sequential Dosing , Single Ascending Dose and Multiple Dose Safety Tolerability and Pharmacokinetic Study

Metastatic Breast Cancer

Jordan
Acasti Pharma Inc.

Completed

Relative Bioavailability of Intravenous GTX-104 Compared to Oral Nimodipine Capsules in Healthy Subjects

Aneurysmal Subarachnoid Hemorrhage

Canada
Acasti Pharma Inc.

Recruiting

Safety and Tolerability of GTX-104 Compared With Oral Nimodipine in Patients With aSAH (STRIVE-ON)

Aneurysmal Subarachnoid Hemorrhage (aSAH)

United States
Kashiv BioSciences, LLC

Completed

To Compare the PK, PD, Safety & Immunogenicity of ADL-018 in Healthy Subjects

Healthy

India
Acasti Pharma Inc.

Active, not recruiting

Single-dose to Evaluate the Pharmacokinetics of GTX-101 and Subcutaneous Injectable Bupivacaine in Healthy Subjects

Postherpetic Neuralgia

Canada
Acasti Pharma Inc.

Completed

A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2) (TRILOGY 2)

Hypertriglyceridemia

United States, Mexico, Canada
Acasti Pharma Inc.

Completed

A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1) (TRILOGY 1)

Hypertriglyceridemia

United States
Marashi Eye Clinic

Completed

SDM Laser for Non Central Diabetic CSME

Non Central Diabetic Macular Edema

Syrian Arab Republic
Tadashi Hasegawa

Completed

Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)

Bipolar Disorder

Japan
Tadashi Watabe

Recruiting

Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts

Neoplasms

Japan
Anup Kasi
Cend Therapeutics Inc.

Recruiting

CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab (CENDIFOX)

Colon Cancer | Pancreas Cancer | Digestive Cancer

United States

Clinical Trials Sponsored by Akashi Therapeutics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations